Therapeutics: Toll-like receptor adaptor molecule 1 (TICAM1; TRIF); toll-like receptor 2 (TLR2); TLR3

Cancer

INDICATION: Solid tumors

Mouse studies suggest a TICAM1-expressing, deglycosylated vaccinia virus could help treat solid tumors. An oncolytic vaccinia virus was engineered

Read the full 214 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE